BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang AP, Long JA, Zhang YJ, Liu ZY, Li QJ, Zhang DM, Luo Y, Zhong RH, Zhou ZG, Xu YJ, Xu XJ, Ling WH, Chen MS, Zhu HL. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival. Hepatology 2020;72:169-82. [PMID: 31677282 DOI: 10.1002/hep.31013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu A, Kuznia S, Niedermaier T, Holleczek B, Schöttker B, Brenner H. Distribution and Determinants of Vitamin D-Binding Protein, Total, "Non-Bioavailable", Bioavailable, and Free 25-Hydroxyvitamin D Concentrations among Older Adults. Nutrients 2021;13:3982. [PMID: 34836237 DOI: 10.3390/nu13113982] [Reference Citation Analysis]
2 Urashima M, Okuyama M, Akutsu T, Ohdaira H, Kaji M, Suzuki Y. Effect of Vitamin D Supplementation on Survival of Digestive Tract Cancer Patients with Low Bioavailable 25-Hydroxyvitamin D levels: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial. Cancers (Basel) 2020;12:E347. [PMID: 32033150 DOI: 10.3390/cancers12020347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Zhai LL, Zhen SH, Tang ZG. Letter to the Editor: Serum bioavailable 25-hydroxyvitamin D levels correlate with hepatocellular carcinoma survival. Hepatology 2021. [PMID: 34536312 DOI: 10.1002/hep.32158] [Reference Citation Analysis]
4 Fang AP, Zhang YJ, Chen MS, Zhu HL. Reply. Hepatology 2021. [PMID: 34536297 DOI: 10.1002/hep.32160] [Reference Citation Analysis]
5 Yishake D, He TT, Liu ZY, Chen S, Luo Y, Liu XZ, Huang RZ, Lan QY, Fang AP, Zhu HL. Dietary protein and prognosis of hepatocellular carcinoma: a prospective cohort study. Food Funct 2021;12:11568-76. [PMID: 34709274 DOI: 10.1039/d1fo02013g] [Reference Citation Analysis]
6 Sluyter JD, Manson JE, Scragg R. Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses. JBMR Plus 2021;5:e10420. [PMID: 33553987 DOI: 10.1002/jbm4.10420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Akutsu T, Kitamura H, Himeiwa S, Kitada S, Akasu T, Urashima M. Vitamin D and Cancer Survival: Does Vitamin D Supplementation Improve the Survival of Patients with Cancer? Curr Oncol Rep 2020;22:62. [PMID: 32495112 DOI: 10.1007/s11912-020-00929-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
8 Yang WS, Zeng XF, Liu ZN, Zhao QH, Tan YT, Gao J, Li HL, Xiang YB. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr 2020;124:330-40. [PMID: 32234090 DOI: 10.1017/S0007114520001208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
9 Yi Z, Wang L, Tu X. Effect of Vitamin D Deficiency on Liver Cancer Risk: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2021;22:991-7. [PMID: 33906289 DOI: 10.31557/APJCP.2021.22.4.991] [Reference Citation Analysis]
10 Liu ZY, Luo Y, Fang AP, Wusiman M, He TT, Liu XZ, Yishake D, Chen S, Lu XT, Zhang YJ, Zhu HL. High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study. Liver Int 2021. [PMID: 34812573 DOI: 10.1111/liv.15100] [Reference Citation Analysis]
11 Sharma VR, Singh M, Kumar V, Yadav M, Sehrawat N, Sharma DK, Sharma AK. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease. Semin Cancer Biol 2021;70:61-70. [PMID: 32693015 DOI: 10.1016/j.semcancer.2020.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Adelani IB, Rotimi OA, Maduagwu EN, Rotimi SO. Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma. Front Oncol 2021;11:642653. [PMID: 34113565 DOI: 10.3389/fonc.2021.642653] [Reference Citation Analysis]